V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017385 | 160020203 | 1.79 | 78.1 | null | 2018-08-10 | 2018-08-17 | GEMCITABINE | 02 | null | NB HRNBL | 100674697 |
| 160017388 | 160020204 | 1.66 | 56.6 | null | 2021-03-26 | 2021-11-05 | Enzalutamide | 02 | null | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 101109548 |
| 160017396 | 160020205 | null | null | Curative (C) | 2021-03-06 | 2021-04-04 | Pemetrexed | null | null | EW EUROEWING 2012 ARM A VAC | 101280426 |
| 160017419 | 160020206 | 1.61 | 82.4 | Curative (C) | 2016-09-07 | 2016-09-14 | Olaparib | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 100343892 |
| 160017435 | 160020207 | 1.6 | 68 | Neo-adjuvant (N) | 2019-10-29 | 2019-10-29 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | IFOSFAMIDE | 100270980 |
| 160017490 | 160020208 | 0 | 90 | null | null | 2019-05-05 | Ifosfamide 3g/m2 5 day | 02 | null | EW EUROEWING 2012 ARM A VAC | 100770715 |
| 160017548 | 160020209 | 1.45 | 67.5 | null | 2016-10-31 | 2016-11-13 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | null | PEMBROLIZUMAB | 100915208 |
| 160017554 | 160020210 | 0.93 | 66.7 | null | 2020-11-15 | 2020-11-28 | Cyclophosphamide + Vincristine | null | null | GEMCITABINE | 101244428 |
| 160017556 | 160020211 | 1.64 | 49.1 | null | 2021-03-05 | 2022-03-12 | CAP | 02 | null | CISPLATIN + ETOPOSIDE | 101502820 |
| 160017573 | 160020212 | 1.72 | 58.7 | Curative (C) | 2016-02-18 | 2016-08-16 | STS Rhabdomyosarcoma RMS 2005 IVADo | null | null | IVA | 100093601 |
| 160017581 | 160020213 | 1.6 | 99.1 | Palliative (P) | 2020-06-04 | 2020-07-02 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | CISPLATIN + GEMCITABINE | 101161754 |
| 160002009 | 160020214 | 1.51 | 60.5 | Curative (C) | 2020-07-17 | 2020-07-17 | Trial Unspecified | null | Y | NEMO TRIAL | 100169851 |
| 160008630 | 160020216 | 1.6 | 74.5 | null | null | 2022-05-27 | Cyclophosphamide + Vincristine | null | null | TRIAL | 100288187 |
| 160009395 | 160020217 | 1.78 | 64.4 | null | 2021-02-05 | 2021-02-14 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | CONFIRM TRIAL | 100169012 |
| 160009800 | 160020218 | 1.57 | 79 | Palliative (P) | 2019-11-05 | 2019-11-07 | Doxorubicin + Ifosfamide | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100706611 |
| 160010801 | 160020219 | 1.7 | 32.4 | Curative (C) | 2017-09-28 | 2017-10-05 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VC | 100508709 |
| 160010938 | 160020220 | 1.84 | 93.7 | null | 2020-03-11 | 2020-04-20 | ETOP 13-18 BEAT-meso Trial | 02 | null | OLARATUMAB | 101163903 |
| 160016067 | 160020223 | 1.65 | 55.4 | Palliative (P) | 2021-12-20 | 2022-04-17 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | TRIAL | 100042257 |
| 160016734 | 160020225 | 1.63 | 13 | null | 2018-10-26 | 2018-11-17 | Cyclophosphamide + Vincristine | 01 | null | CONFIRM TRIAL | 100068510 |
| 160012407 | 160020264 | null | null | null | 2019-12-21 | 2020-01-11 | null | null | null | CARBOPLATIN + PEMETREXED | 101755774 |
| 160012426 | 160020265 | null | null | null | null | 2022-02-08 | null | null | null | CARBOPLATIN + PEMETREXED | 100152789 |
| 160012891 | 160020274 | null | null | null | 2018-11-12 | 2019-01-31 | null | null | null | CARBOPLATIN + PEMETREXED | 101578003 |
| 160012933 | 160020275 | null | null | null | null | 2021-11-11 | null | N | null | CARBOPLATIN + PEMETREXED | 101799509 |
| 160013194 | 160020278 | null | null | null | null | 2018-07-22 | null | null | null | CARBOPLATIN + PEMETREXED | 100674482 |
| 160013301 | 160020279 | null | null | null | 2019-09-13 | 2019-11-01 | null | null | null | CARBOPLATIN + PEMETREXED | 101445911 |
| 160013374 | 160020280 | null | null | null | null | null | null | null | null | CARBOPLATIN + PEMETREXED | 100159492 |
| 160013471 | 160020282 | null | null | null | 2022-02-08 | 2022-04-06 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101145327 |
| 160013913 | 160020291 | 1.56 | 59.6 | Palliative (P) | 2021-07-06 | 2021-07-12 | Trabectedin | N | N | TRABECTEDIN | 101348740 |
| 160014037 | 160020292 | 1.63 | 76.9 | Palliative (P) | 2019-08-01 | 2019-08-12 | Trabectedin | null | N | TRABECTEDIN | 100243025 |
| 160014282 | 160020293 | 1.54 | 94.6 | Palliative (P) | 2017-10-25 | 2017-10-26 | Trabectedin | 02 | null | TRABECTEDIN | 100985017 |
| 160014350 | 160020294 | 1.72 | 65 | Palliative (P) | 2021-01-25 | 2021-02-08 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100135632 |
| 160014373 | 160020295 | 1.65 | 101 | Palliative (P) | 2019-05-23 | 2019-05-24 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101243440 |
| 160014387 | 160020296 | 1.65 | 110 | null | 2020-02-25 | 2020-03-18 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101118890 |
| 160014405 | 160020298 | 1.55 | 87.7 | null | 2017-11-14 | 2018-04-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101068634 |
| 160014474 | 160020299 | 1.75 | 71.3 | Palliative (P) | 2021-06-19 | 2021-06-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100567955 |
| 160014513 | 160020300 | 1.63 | 68.9 | Palliative (P) | 2020-09-18 | 2021-01-30 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100533218 |
| 160014516 | 160020301 | 1.69 | 80 | Palliative (P) | 2020-11-01 | 2020-11-07 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100405224 |
| 160014517 | 160020302 | 0 | 83.6 | Palliative (P) | 2019-06-16 | 2019-06-21 | Trabectedin | 02 | N | TRABECTEDIN | 100697104 |
| 160014545 | 160020303 | 1.65 | 39.5 | null | null | null | NIVOLUMAB | 02 | null | NIVOLUMAB | 100089872 |
| 160014583 | 160020304 | 1.72 | 73.9 | null | 2022-04-05 | 2022-04-18 | DOXORUBICIN | null | null | DOXORUBICIN | 100308658 |
| 160014860 | 160020305 | 1.64 | 74 | Palliative (P) | 2019-10-20 | 2019-10-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101077483 |
| 160014994 | 160020307 | 1.63 | 118.3 | Palliative (P) | 2017-04-13 | 2017-05-18 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100444770 |
| 160015057 | 160020308 | 1.61 | 82.7 | Palliative (P) | 2021-10-30 | 2021-10-30 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101592374 |
| 160015074 | 160020309 | 1.77 | 96.2 | Palliative (P) | 2019-09-24 | 2019-10-07 | DOXORUBICIN | 02 | N | TRABECTEDIN | 100160974 |
| 160015091 | 160020310 | 1.84 | 95.05 | Palliative (P) | 2019-09-22 | 2019-09-28 | Vinorelbine (oral) | 01 | N | VINORELBINE | 100361432 |
| 160015278 | 160020312 | 1.58 | 105.3 | Palliative (P) | 2020-03-04 | 2020-03-12 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100252141 |
| 160015290 | 160020313 | 1.83 | 65.5 | Palliative (P) | 2017-08-24 | 2017-08-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101658935 |
| 160015343 | 160020314 | 1.73 | 75.6 | null | 2020-08-22 | 2021-02-07 | Doxorubicin 75mg/m2 | null | null | TRABECTEDIN | 100568238 |
| 160015378 | 160020315 | 1.77 | 56.6 | null | 2019-01-14 | 2019-01-15 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 100356244 |
| 160015420 | 160020316 | 1.43 | 72.6 | Palliative (P) | 2021-02-03 | 2021-02-04 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101071981 |